Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? [1] (multiple letters)

Homer Abiad, Kelly Elise Dooley, Jonathan E Golub, Timothy R. Sterling

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1572-1573
Number of pages2
JournalClinical Infectious Diseases
Volume35
Issue number12
StatePublished - Dec 15 2002

Fingerprint

Drug Administration Schedule
Antitubercular Agents
Bacterial Pneumonia
Fluoroquinolones
Anti-Infective Agents
Diagnostic Errors
Pneumonia
Tuberculosis
Research Design

ASJC Scopus subject areas

  • Immunology

Cite this

@article{ce54b6d064774f1d8fed3a788c8709b0,
title = "Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? [1] (multiple letters)",
author = "Homer Abiad and Dooley, {Kelly Elise} and Golub, {Jonathan E} and Sterling, {Timothy R.}",
year = "2002",
month = "12",
day = "15",
language = "English (US)",
volume = "35",
pages = "1572--1573",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis? [1] (multiple letters)

AU - Abiad, Homer

AU - Dooley, Kelly Elise

AU - Golub, Jonathan E

AU - Sterling, Timothy R.

PY - 2002/12/15

Y1 - 2002/12/15

UR - http://www.scopus.com/inward/record.url?scp=0037115356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037115356&partnerID=8YFLogxK

M3 - Article

C2 - 12471582

AN - SCOPUS:0037115356

VL - 35

SP - 1572

EP - 1573

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -